Literature DB >> 7573262

Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial.

T Vutyavanich1, S Wongtra-ngan, R Ruangsri.   

Abstract

OBJECTIVE: Our purpose was to determine the effectiveness of pyridoxine for nausea and vomiting of pregnancy. STUDY
DESIGN: During an 11-month period 342 women who first attended Chiang Mai University Hospital antenatal clinic at < or = 17 weeks' gestation were randomized to received either oral pyridoxine hydrochloride, 30 mg per day, or placebo in a double-blind fashion. Patients graded the severity of their nausea by a visual analog scale and recorded the number of vomiting episodes over the previous 24 hours before treatment and again during 5 consecutive days on treatment.
RESULTS: There was a significant decrease in the mean of posttherapy minus baseline nausea scores in the pyridoxine compared with that in the placebo group (t test, p = 0.0008). There was also a greater reduction in the mean number of vomiting episodes, but the differences did not reach statistical significance (p = 0.0552).
CONCLUSION: Pyridoxine is effective in relieving the severity of nausea in early pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7573262     DOI: 10.1016/0002-9378(95)90359-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

Review 1.  Treatment options for hyperemesis gravidarum.

Authors:  Amy Abramowitz; Emily S Miller; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2017-01-09       Impact factor: 3.633

Review 2.  A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors:  P Mazzotta; L A Magee
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 3.  Vitamin supplementation for preventing miscarriage.

Authors:  Olukunmi O Balogun; Katharina da Silva Lopes; Erika Ota; Yo Takemoto; Alice Rumbold; Mizuki Takegata; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

4.  Suboptimal maternal and cord plasma pyridoxal 5' phosphate concentrations are uncommon in a cohort of Canadian pregnant women and newborn infants.

Authors:  Lesley Plumptre; Shannon P Masih; Kyoung-Jin Sohn; Denise Kim; Carly E Visentin; Anna Ly; Howard Berger; Ruth Croxford; Deborah L O'Connor; Young-In Kim
Journal:  Matern Child Nutr       Date:  2017-05-24       Impact factor: 3.092

Review 5.  Interventions for nausea and vomiting in early pregnancy.

Authors:  Anne Matthews; Therese Dowswell; David M Haas; Mary Doyle; Dónal P O'Mathúna
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 6.  Treatment of nausea and vomiting in pregnancy. When should it be treated and what can be safely taken?

Authors:  C Nelson-Piercy
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

7.  Optimal management of nausea and vomiting of pregnancy.

Authors:  Neda Ebrahimi; Caroline Maltepe; Adrienne Einarson
Journal:  Int J Womens Health       Date:  2010-08-04

Review 8.  Nausea and vomiting of pregnancy - What's new?

Authors:  Martha Bustos; Raman Venkataramanan; Steve Caritis
Journal:  Auton Neurosci       Date:  2016-05-13       Impact factor: 3.145

Review 9.  Interventions for nausea and vomiting in early pregnancy.

Authors:  Anne Matthews; David M Haas; Dónal P O'Mathúna; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2015-09-08

Review 10.  Doxylamine succinate-pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an overview.

Authors:  Nina Nuangchamnong; Jennifer Niebyl
Journal:  Int J Womens Health       Date:  2014-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.